Cosmos Health Inc (COSM) is undervalued and EDAP TMS SA ADR (FOCL) is overvalued.
Against our estimates of intrinsic value, COSM trades at the wider discount: a margin of safety of +52%, against -91% for FOCL.
Values as of the 22 Sept 2026 close.
A 1.2x revenue multiple, discounted for its losses, values the shares at $0.73; the price of $0.35 is 52% below that value.
Leak Score 56/100 on 2 of 12 signals
A 1.5x revenue multiple, discounted for its losses, values the shares at $2.24; the price of $4.27 is 91% above that value.
Leak Score 0/100 on 2 of 12 signals
| Metric | COSM | FOCL |
|---|---|---|
| Verdict | Undervalued | Overvalued |
| Price | $0.35 | $4.27 |
| Intrinsic value | $0.73 | $2.24 |
| Margin of safety | +52% | -91% |
| Leak Score | 56/100 (2/12) | 0/100 (2/12) |
| Market cap | $36M | $160M |
| Revenue growth, 5 years | 3.3% | 8.3% |
| Operating margin | -24.6% | -39.3% |
| Net margin | -33.1% | -56.3% |
| Return on equity | -104.0% | -263.8% |
| Debt to equity | 0.80 | — |
| Forward P/E | 5.1x | — |
| P/B | 1.4x | — |